These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19134194)

  • 1. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.
    Kleiner HE; Krishnan P; Tubbs J; Smith M; Meschonat C; Shi R; Lowery-Nordberg M; Adegboyega P; Unger M; Cardelli J; Chu Q; Mathis JM; Clifford J; De Benedetti A; Li BD
    J Exp Clin Cancer Res; 2009 Jan; 28(1):5. PubMed ID: 19134194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLK1B is elevated with eIF4E overexpression in breast cancer.
    Norton KS; McClusky D; Sen S; Yu H; Meschonat C; Debenedetti A; Li BD
    J Surg Res; 2004 Jan; 116(1):98-103. PubMed ID: 14732354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
    Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.
    Byrnes KW; DeBenedetti A; Holm NT; Luke J; Nunez J; Chu QD; Meschonat C; Abreo F; Johnson LW; Li BD
    J Am Coll Surg; 2007 May; 204(5):925-33; discussion 933-4. PubMed ID: 17481512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival.
    Wheater MJ; Johnson PW; Blaydes JP
    Cancer Biol Ther; 2010 Oct; 10(7):728-35. PubMed ID: 20686366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma.
    Hu A; Sun M; Yan D; Chen K
    Tumori; 2014; 100(5):541-6. PubMed ID: 25343550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
    Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
    Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.
    Li BD; McDonald JC; Nassar R; De Benedetti A
    Ann Surg; 1998 May; 227(5):756-6l; discussion 761-3. PubMed ID: 9605667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eIF4E expression in tumors: its possible role in progression of malignancies.
    De Benedetti A; Harris AL
    Int J Biochem Cell Biol; 1999 Jan; 31(1):59-72. PubMed ID: 10216944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD; Gruner JS; Abreo F; Johnson LW; Yu H; Nawas S; McDonald JC; DeBenedetti A
    Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
    Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
    Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
    Soni A; Akcakanat A; Singh G; Luyimbazi D; Zheng Y; Kim D; Gonzalez-Angulo A; Meric-Bernstam F
    Mol Cancer Ther; 2008 Jul; 7(7):1782-8. PubMed ID: 18644990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
    Phillips A; Blaydes JP
    Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming.
    Geter PA; Ernlund AW; Bakogianni S; Alard A; Arju R; Giashuddin S; Gadi A; Bromberg J; Schneider RJ
    Genes Dev; 2017 Nov; 31(22):2235-2249. PubMed ID: 29269484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
    Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
    Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.